T3 Pharmaceuticals Company
T3 Pharmaceuticals aims to enhance the quality of life of cancer patients through the development of innovative treatments using live bacteria. The company is focused on creating highly specific and efficient therapies to address the existing gap in cancer treatment.
Investors
.jpg)
Connections
Founded Date:
2015
Headquarters:
Basel
Employee Number:
1-10
Industry:
FinTech
Estimated Revenue:
up to 450 million CHF